Clinical trial
Fluoxetine as a Quit Smoking Aid for Depression-Prone Smokers
NCT00018174 · US Department of Veterans Affairs, U.S. Fed · Completed
Key facts
| NCT number | NCT00018174 |
|---|---|
| Title | Fluoxetine as a Quit Smoking Aid for Depression-Prone Smokers |
| Official title | Fluoxetine as a Quit Smoking Aid for Depression-Prone Smokers |
| Lead sponsor | US Department of Veterans Affairs, U.S. Fed |
| Collaborators | Eli Lilly and Company Industry |
| Status | Completed |
| Phase | Phase 3 |
| Study type | Interventional |
| Conditions | Depression, Smoking |
| Intervention type | Behavioral, Drug |
| Interventions | Fluoxetine, Behavioral group smoking cessation treatment, Placebo |
| Enrollment | 247 |
| Start date | Feb 1, 1998 |
| Primary completion | Jan 1, 2003 |
| Completion | Jan 1, 2005 |
| First posted | Jul 5, 2001 |
| Last update posted | Mar 2, 2009 |
| Countries | United States |
At a glance
- 1–9 Study sites
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: